GlassScriptPhysician profile
Abdur Raziq
NPI 1275948226
$1,095.25
in general payments reported to CMS, 2019-2025
16 companies · $170 in 2025
The $170 reported for 2025 was more than what a typical Hospitalist provider received nationally (typical 2025 total: $85.87).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $208 · 2023: $237 · 2024: $480 · 2025: $170.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $887.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $887.09 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novartis Pharmaceuticals Corporation | $179.30 | 2022-2024 | |
| Abbvie INC. | $163.36 | 2022-2025 | |
| Novo Nordisk INC | $123.81 | 2022 | |
| Janssen Pharmaceuticals, INC | $112.43 | 2022-2024 | Xarelto |
| Pfizer INC. | $97.12 | 2024-2025 | |
| Astrazeneca Pharmaceuticals LP | $90.53 | 2023-2024 | Lokelma, Farxiga |
| E.R. Squibb & Sons, L.L.C. | $53.39 | 2022-2023 | Camzyos |
| Merck Sharp & Dohme LLC | $46.73 | 2024-2025 | Verquvo |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $45.63 | 2024 | Xifaxan |
| Bayer Healthcare Pharmaceuticals INC. | $43.77 | 2025 | |
| Lexicon Pharmaceuticals, INC. | $35.78 | 2024 | |
| Mallinckrodt Hospital Products INC. | $24.81 | 2024 | Terlivaz |
| Boston Scientific Corporation | $21.94 | 2025 | Watchman Flx |
| Aimmune Therapeutics, INC. | $20.90 | 2024 | |
| Alexion Pharmaceuticals, INC. | $19.35 | 2023 | Ultomiris |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boehringer Ingelheim Pharmaceuticals, INC. | $16.40 | 2024 | Jardiance |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Abdur Raziq listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.